Literature DB >> 2412036

Chronic effects of serotonin inhibition in hypertensive patients: hemodynamic and humoral findings.

P W de Leeuw, W H Birkenhäger.   

Abstract

This review deals with the effects of chronic antihypertensive treatment with ketanserin on a series of physiological and biochemical variables, both at rest and during stimulation (exercise or stress). In four centers, different aspects were covered, with blood pressure as the common denominator in 45 hypertensive patients. Treatment periods ran from 1 to 9 months with daily doses ranging from 80 to 160 mg. Systolic and diastolic pressures fell roughly by 10 mm Hg. Heart rate tended to be reduced. The decrease in blood pressure was accounted for mainly by a decrease in calculated total peripheral (and renal) vascular resistance. Volume parameters failed to show statistically significant changes, although plasma volume tended to expand. The profile of hemodynamics during exercise was basically unmodified. Hormonal changes were not uniform, but the main trend was a decrease in the activities of both the renin-angiotensin and the adrenergic system. Apparently the action of ketanserin is not confined to 5-HT2-serotonergic blockade.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412036     DOI: 10.1097/00005344-198500077-00040

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  2 in total

1.  Antihypertensive effect of long term ketanserin in elderly essential hypertensive patients. Assessment of left ventricular function at rest and during exercise.

Authors:  R A Sánchez; F Otero; A J Ramírez; O Degrossi; J Glenny; E J Marcó
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  Ketanserin in essential hypertension: use as monotherapy and in combination with a diuretic or beta-adrenoceptor antagonist.

Authors:  H A Cameron; P C Waller; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.